Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer-Reference-Cited by-同舟云学术

Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer

Published:2022-12 Issue: Volume:66 Page:69-76
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Bahl Amit,Wilson William,Ball Jessica^ORCID,Renninson Emily^ORCID,Dubey Sidharth,Bravo Alicia,Foulstone Emily,Spensley Saiqa,Bowen Rebecca,Mansi Janine,Waters Simon,Riddle Pippa,Wheatley Duncan,Stephens Peter,Bezecny Pavel,Madhusudan Srinivasan,Verrill Mark,Braybrooke Jeremy^ORCID,Comins Charles,Mohan Vivek,Gee Abigail,Kirk Hannah,Markham Alison^ORCID,Evans Heidi,Watson Eve,Callaway Mark,Pearson Sylvia,Hackshaw Allan,Churn Mark

Funder

Sanofi US

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference32 articles.

1. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)dagger;Cardoso;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2018

2. Managing advanced breast cancer”,2020

3. Inclusion of taxanes, particularly weekly Paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers;Mazouni;Ann Oncol,2007

4. Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE);ESMO Open;2024-05

2. Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants;International Journal of Nanomedicine;2024-03

3. Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review;Pharmaceutics;2023-04-24